Generic Alternatives to Prescription Drugs: Your Guide to Buying Effective Drugs at Cost-Saving Prices
AppShopper.com: Price Changes (Free subscription) | 3 hours ago
Rx Guide Pro 1.5 Category: Medical Price: $1.99 -> $0.99 ( iTunes ) Description: ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ What's in your wallet? Instant access to 5,000 FDA approved package inserts plus generic drug for brand name. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Rx Guide Pro is designed to help medical professionals to make clinical decisions more promptly and confidently. Rx Guide Pro contains...
MassDevice - Medical device news, information and jobs... (Free subscription) | yesterday
Millipore Corp. buys out its Indian joint venture partner's 60 percent stake in Millipore India. Millipore Corp. (NYSE:MIL) bought out the remaining 60 percent stake in its Indian subsidiary for an undisclosed amount. The Billerica, Mass.-based lab instruments maker said the deal is part of its push into developing markets in Brazil, Russia, India, China and Singapore. Citing the more than 80 plants...
Joseph Kim, MD, MPH (Free subscription) | 21/11/2009
Have you heard of the International Internet Week of Action (IIWA)? The other day, the FDA completed a coordinated international effort called the International Internet Week of Action (IIWA). The code name for this operation was Operation Pangea II and it was intended to curb illegal actions involving medical products. According to the FDA: The IIWA provided an opportunity to enhance cooperation among...
Red Orbit (Free subscription) | 20/11/2009
First study to quantify savingsPurchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time.An analysis of 26,852 prescriptions filled for 395 different drugs from 2000-2005 showed that patients...
Pharmalot (Free subscription) | 19/11/2009
European regulators will ask brand-name drugmakers for details of their deals with generic companies as part a crackdown on firms suspected of blocking cheaper treatments, a European Commission official disclosed, according to Reuters. Last July, you may recall, European Union competition commissioner Neelie Kroes issued a report saying that delays in bringing generic drugs to the [...]
Medical News Today (Free subscription) | 19/11/2009
"Teva Pharmaceuticals, a leading manufacturer of generic drugs, has been aggressively lobbying Congress to scrap provisions in the health care bills it claims would shut it out of the biologic drug market for too long," Roll Call reports.
ireland.com (Free subscription) | 19/11/2009
Pharmaceutical giant Pfizer said today it may start selling generic drugs in Japan from 2011 as part of its efforts to diversify its operations.
The Street (Free subscription) | 19/11/2009
Pfizer plans to start selling generic drugs in Japan beginning in 2011, a spokesman said, according to reports.
Fiercebiotech (Free subscription) | 18/11/2009
Peter Thompson , Trubion Pharmaceuticals' president, CEO, chairman of the board and co-founder, has retired. Steven Gillis , former lead director of Trubion's board, has been appointed executive chairman of the board and acting president. Michelle Burris , Trubion's senior vice president and chief financial officer, will assume the role of chief operating officer, and John Bencich , the company's...
post-gazette.com (Free subscription) | 18/11/2009
Health-care reform was always going to be difficult to achieve, but it may yet turn out to be the best that money can buy -- except that it may be special-interest money buying what it wants, not promoting the public interest. If the public ever lacked for an example of this sad state of affairs, a New York Times story on Sunday provided one. It chronicled how statements submitted by lawmakers to...
Slog (Free subscription) | 17/11/2009
A few days ago, a major Washington State union trust elected Qliance—a local primary-care facility—as an option in its health-benefits plan. That's a snoozer of a lead, isn't it? Here's why it matters: Organizations like Qliance might save the American health care system. Or American health in general. From a profile of Qliance earlier this year: In the fall of 2005, Erika Bliss, MD, was...
Ecuador Rising - Hatarinchej (Free subscription) | 17/11/2009
QUITO – The Ecuadorian government said Thursday in justifying its decision to bypass patents and facilitate the production of lower-cost versions of certain medicines that health “takes precedence” over commercial interests. Health Minister Caroline Chang told Efe that principle is enshrined in Ecuador’s constitution and noted the existence of international accords that authorize...
PR News Wire (Free subscription) | 16/11/2009
NANTONG, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC Bulletin Board: SNBP) is pleased to announce that 23 generic drugs for which the Company has production rights are listed in China's National Essential Drugs List, which covers pharmaceuticals used to treat up to 80 percent of the most common diseases in China.
The Irish Times (Free subscription) | 16/11/2009
Nutritional supplements and some prescription drugs may be removed from State schemes, writesDr Muiris Houston
Videos